Alexander Ostrovsky in Langhorne, Pennsylvania

Home Pennsylvania Langhorne

Alexander Ostrovsky has Hematology/oncology as his primary medical specialty. Their primary office is: 1203 Langhorne Newtown Rd in Langhorne, Pennsylvania.

They're a part of the: Alliance Cancer Specialists medical group which has around 54 members. You can call their office at 215-750-5050 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1985 (around 40 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Alexander Ostrovsky Office Phone and Directions

Alexander Ostrovsky
Alliance Cancer Specialists
1203 Langhorne Newtown Rd
Langhorne, Pennsylvania 19047
215-750-5050

Patient Ratings
Please rate your experience with Alexander Ostrovsky below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 215-750-5050

Enter a starting address:

Healthcare Info for Alexander Ostrovsky

Medical School: Sorry, his university is not listed
Graduation Year: 1985
The Primary Medical Specialty for Alexander Ostrovsky is listed as: Hematology/oncology
Approximate Years of Experience: 40
PAC (PECOS ID)#: 8820274830
NPI #: 1548310238
NPI Created On: 01/12/2007
NPI Last Updated Listed as: 07/21/2010
Primary Taxonomy Code: 207RH0003X
License Number:
MD073726L
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

AmeriHealth New Jersey
Blue Cross Blue Shield
Highmark Health Insurance Company
AmeriHealth HMO, Inc.
Humana
Highmark Inc.
Geisinger Health Plan
Geisinger Quality Options
Pennsylvania Health & Wellness, Inc.
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: Russian, English.

Services and Procedures include:

Insertion of needle into vein for collection of blood sample
Complete blood cell count (red cells, white blood cell, platelets), automated test
Hydration infusion into a vein 31 minutes to 1 hour
Hydration infusion into a vein
Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle
Infusion of chemotherapy into a vein up to 1 hour
Infusion of chemotherapy into a vein
New patient office or other outpatient visit, typically 30 minutes
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371533

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371535

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-140-09

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: DARZALEX

Associated Drug #2: 57894-502-05

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788371537

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09

Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013685

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781013687

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801691309

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149795

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149809

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60

Payments Total: $19

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783612261

Being Disputed:: No

Product Related: No

Payments Total: $24

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783612269

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Hematology/oncology Professionals in Langhorne

1.
Arezoo Ghaneie MD

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

2.
Carlin Mclaughlin

240 Middletown Blvd
Langhorne, PA
Clinical Care Associates Of The University Of Pennsylvania Health

3.
Daniel Lebovic

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

4.
Marc Chernoff DO

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

5.
Peter Pickens

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

6.
Frederick Dold

1203 Langhorne Newtown Rd
Langhorne, PA
Alliance Cancer Specialists

Providers in Alliance Cancer Specialists

1.Bineetha Abraham

1000 Floral Vale Blvd
Yardley Pa 19067-5583
Alliance Cancer Specialists
Nurse Practitioner

2.Bineetha Abraham

2630 Holme Ave
Philadelphia Pa 19152-3004
Alliance Cancer Specialists
Nurse Practitioner

3.Sramila Aithal

1311 Bristol Pike
Bensalem Pa 19020-6415
Alliance Cancer Specialists
Hematology/oncology

4.Mitchell Alden

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

5.Zonera Ali Md

1203 Langhorne Newtown Rd
Langhorne Pa 19047-1212
Alliance Cancer Specialists
Hematology/oncology

6.Zonera Ali Md

100 E Lancaster Ave
Wynnewood Pa 19096-3450
Alliance Cancer Specialists
Hematology/oncology

View all 54 members of Alliance Cancer Specialists medical group